Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma (HCC). Antiviral agents are thought to reduce HCC development, but agents such as lamivudine (LAM) have a high rate of drug resistance. We compared the incidence of HCC in 472 entecavir (ETV)-treated patients a...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | engelska |
| Publicerad: |
2012
|
| Länkar: | https://doi.org/10.1002/hep.26180 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26180 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|